Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
作者： Mudasir Maqbool , Mohammad Mobashir , Nasimul Hoda
DOI: 10.1016/J.EJMECH.2015.10.018
关键词:
摘要: Neurodegenerative diseases are among the most challenging diseases with poorly known mechanism of cause and paucity of complete cure. Out of all the neurodegenerative diseases…
sci-hub.se 参考文章(188)
Andrzej Pilc, Bernadeta Szewczyk, Gabriel Nowak, Zinc and depression. An update. Pharmacological Reports. ,vol. 57, pp. 713- 718 ,(2005)
William T. Salter, Ira T. Nathanson, Hildegarde Wilson, Experimentally Induced Benignancy of Neoplasm. V. The Influence of Hormones on the Host's Resistance to Implanted Neoplasm Cancer Research. ,vol. 1, pp. 60- 64 ,(1941)
Rajâa Boulahjar, Aziz Ouach, Stéphane Bourg, Pascal Bonnet, Olivier Lozach, Laurent Meijer, Christiane Guguen-Guillouzo, Rémy Le Guevel, Saïd Lazar, Mohamed Akssira, Yves Troin, Gérald Guillaumet, Sylvain Routier, Advances in tetrahydropyrido[1,2- a ]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors European Journal of Medicinal Chemistry. ,vol. 101, pp. 274- 287 ,(2015) , 10.1016/J.EJMECH.2015.06.046
Matthew Schrag, Andrew Crofton, Matthew Zabel, Arshad Jiffry, David Kirsch, April Dickson, Xiao Wen Mao, Harry V. Vinters, Dylan W. Domaille, Christopher J. Chang, Wolff Kirsch, Effect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease Journal of Alzheimer's Disease. ,vol. 24, pp. 137- 149 ,(2011) , 10.3233/JAD-2010-101503
Ratan V. Bhat, Samantha L. Budd Haeberlein, Jesús Avila, Glycogen synthase kinase 3: a drug target for CNS therapies Journal of Neurochemistry. ,vol. 89, pp. 1313- 1317 ,(2004) , 10.1111/J.1471-4159.2004.02422.X
Laura Dugo, Marika Collin, David A. Allen, Nimesh S. A. Patel, Inge Bauer, Eero M. A. Mervaala, Marjut Louhelainen, Simon J. Foster, Muhammad M. Yaqoob, Christoph Thiemermann, Inhibiting glycogen synthase kinase 3beta in sepsis. Sepsis: new insights, new therapies. Novartis Foundation Symposium No. 280, London, UK, 14-16 February 2006.. ,vol. 280, pp. 128- 146 ,(2007) , 10.1002/9780470059593.CH9
Christopher J. Phiel, Christina A. Wilson, Virginia M.-Y. Lee, Peter S. Klein, GSK-3α regulates production of Alzheimer's disease amyloid-β peptides Nature. ,vol. 423, pp. 435- 439 ,(2003) , 10.1038/NATURE01640
Claudie Hooper, Richard Killick, Simon Lovestone, The GSK3 hypothesis of Alzheimer's disease. Journal of Neurochemistry. ,vol. 104, pp. 1433- 1439 ,(2008) , 10.1111/J.1471-4159.2007.05194.X
M. Obulesu, R. Venu, R. Somashekhar, Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity. Acta Neurologica Scandinavica. ,vol. 124, pp. 295- 301 ,(2011) , 10.1111/J.1600-0404.2010.01483.X
Suzanne M. de la Monte, Ming Tong, Nataniel Lester-Coll, Michael Plater, Jr., Jack R. Wands, Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 10, pp. 89- 109 ,(2006) , 10.3233/JAD-2006-10113